DCLA
AGN

Douglas C. Lane & Associates’s Allergan plc AGN Stock Holding History

Douglas C. Lane & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$215K Sell
689
-310
-31% -$92.3K 0.01% 210
2015
Q3 		$272K Buy
999
+288
+41% +$88.5K 0.01% 202
2015
Q2 		$216K Buy
+711
New +$212K 0.01% 216

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Douglas C. Lane & Associates's AGN Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Allergan plc (AGN) stake by 31% in Q4 2015, selling an estimated $92.3K and leaving 689 shares worth $215K. The position accounts for 0.01% of the portfolio, ranked #210.

Douglas C. Lane & Associates first reported a position in AGN in Q2 2015 and has held it in 3 quarters since. The position peaked at $272K in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Douglas C. Lane & Associates held 689 shares of Allergan plc worth $215K as of Q4 2015.
  • Douglas C. Lane & Associates sold 310 Allergan plc shares in Q4 2015, an estimated $92.3K.
  • Allergan plc made up 0.01% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #210 holding.
  • Douglas C. Lane & Associates first reported a position in Allergan plc in Q2 2015 and has held it in 3 quarters since.
  • Douglas C. Lane & Associates's Allergan plc position peaked at $272K in Q3 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.